Index/Topics/Intracavernosal Injections

Intracavernosal Injections

Use of intracavernosal injections for treating erectile dysfunction after prostatectomy.

Fact-Checks

11 results
Jan 18, 2026
Most Viewed

How do vacuum erection devices compare to other ED treatments in long-term safety?

Vacuum erection devices (VEDs) are a noninvasive, well‑established treatment for erectile dysfunction (ED) with consistently reported low long‑term morbidity and high continuation/satisfaction rates i...

Jan 18, 2026
Most Viewed

How soon after catheter removal is it safe to begin different penile rehabilitation modalities (PDE5-Is, VED, masturbation, injections)?

Early penile rehabilitation is commonly recommended after radical prostatectomy, but exact timing varies by modality and by clinician; many centers start oral PDE5 inhibitors at the time the catheter ...

Jan 26, 2026
Most Viewed

What clinical trials have tested sodium bicarbonate for vascular or erectile outcomes?

A single, small randomized clinical trial tested in the specific setting of and found it reduced injection-related penile pain in 38 patients , while a broad review of available reporting finds no rob...

Jan 25, 2026

What are the proven medical treatments for erectile dysfunction and how do they compare?

Phosphodiesterase type 5 inhibitors () — oral drugs such as sildenafil, tadalafil and avanafil — are the established, first-line, evidence-based treatments for because they reliably improve erections ...

Jan 18, 2026

How effective are pumps compared with PDE5 inhibitors and penile injections for long‑term erectile function restoration?

PDE5 inhibitors are the established first‑line therapy for ED with roughly 60–70% initial response and substantial evidence that chronic/daily use can help preserve or improve long‑term erectile funct...

Feb 5, 2026

How do vacuum erection devices compare to medications and penile implants for erectile dysfunction?

(VEDs) are a non‑drug, non‑surgical option that reliably produces erections for many men and plays an important role in penile rehabilitation after , but they tend to be less favored for rigidity and ...

Jan 31, 2026

What are the long‑term outcomes and complication rates of penile prostheses versus intracavernosal injections?

Penile prostheses offer a durable, often definitive solution for refractory with consistently high long‑term patient satisfaction and improving complication profiles as devices and techniques evolve ....

Jan 18, 2026

What randomized trials compare vacuum erection devices, PDE5 inhibitors, and intracavernosal injections for penile rehabilitation after radical prostatectomy?

Randomized trials exist for each modality—PDE5 inhibitors (PDE5i), vacuum erection devices (VED), and intracavernosal injections (ICI)—and several randomized studies and systematic reviews report bene...

Jan 15, 2026

How do combination protocols (VED + PDE5i or injections) compare to single‑modality therapy after radical prostatectomy?

Combination penile-rehabilitation protocols—typically a vacuum erectile device (VED) plus a phosphodiesterase‑5 inhibitor (PDE5i), or combinations that include intracavernosal injections (ICI)—general...

Jan 14, 2026

How does vacuum therapy compare to oral ED medications and penile injections in effectiveness and side effects?

Vacuum erection devices (VEDs), oral phosphodiesterase‑5 inhibitors (PDE5i), and intracavernosal injections are all established ED therapies with different mechanisms, strengths, and trade‑offs: oral ...

Jan 8, 2026

What is the average penis girth in clinical studies?

A large clinician‑measured meta‑analysis puts average flaccid penis girth at about 9.31 cm (3.66–3.67 in) and average erect girth at about 11.66 cm (4.59 in) based on pooled measurements of over 15,00...